Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2005
12/29/2005WO2005059505A3 Method and kit for the genotypification of hla-b27 based on real time pcr
12/29/2005WO2005059163A3 Methods, compositions, and kits for analysis of enzyme activity in cells
12/29/2005WO2005053516A3 Replication competent hepatitis c virus and methods of use
12/29/2005WO2005049806A3 Novel nucleic acids and polypeptides
12/29/2005WO2005043119A3 Methods and compositions for the identification of anti-poxvirus agents
12/29/2005WO2005042706A3 Ephx2 genetic markers associated with galantamine response
12/29/2005WO2005042552A3 Modulation of sglt2 expression
12/29/2005WO2005040427A3 Inversion on chromosome 8p23 is a risk factor for anxiety disorders, depression and bipolar
12/29/2005WO2005040353A3 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv
12/29/2005WO2005040352A3 Immunogenic composition and method of developing a vaccine based on factor h binding sites
12/29/2005WO2005038370A3 Genetic markers for obesity
12/29/2005WO2005010159A3 Rolling circle amplification of micro-rna samples
12/29/2005WO2005004814A3 Sirt1 and genetic disorders
12/29/2005WO2005001043A3 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi
12/29/2005WO2005000098A3 Detection methods for disorders of the lung
12/29/2005WO2004103269A3 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
12/29/2005WO2004099228A3 Variants of beta-glucosidases
12/29/2005WO2004084832A3 Measurement of estrogen activity in plants and a composition therefrom
12/29/2005WO2004069166A3 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
12/29/2005WO2004053099A3 A method for treatment of drug addiction and for screening of pharmaceutical agents therefor
12/29/2005WO2004046341A3 Modulation of kiaa0415 expression
12/29/2005WO2004044154A3 Methods of identifying antineoplastic agents
12/29/2005WO2004038366A3 ISOTHERMAL AMPLIFICATION BASED ASSAY FOR THE DETECTION AND QUANTITATION OF ALPHA-FETOPROTEIN mRNA
12/29/2005WO2004037992A3 Mapk7 as modifier of branching morphogenesis and methods of use
12/29/2005WO2004033659A3 Novel tumor suppressor gene and compositions and methods for making and using the same
12/29/2005WO2004026820A3 Method for assaying compounds that decrease the activity of poly(adp-ribose)-polymerase (parp)
12/29/2005WO2004015073A3 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
12/29/2005WO2003072799A3 Brother of the regulator of imprinted sites (boris)
12/29/2005WO2003071933A3 Novel compositions and methods for cancer
12/29/2005WO2002099040A3 Igs as modifiers of the p53 pathway and methods of use
12/29/2005WO2002074789A3 Use of monoclonal antibodies and functional assays for prediction of risk of opportunistic infection
12/29/2005WO2002033113A3 Protein-protein interactions in neurodegenerative diseases
12/29/2005US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
12/29/2005US20050289657 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
12/29/2005US20050288870 Number coding for identification of subtypes of coded types of solid phase carriers
12/29/2005US20050288867 Cell tissue culture management method and system
12/29/2005US20050288865 Peptide and protein identification method
12/29/2005US20050288497 Responsiveness to therapy for liver disorders
12/29/2005US20050288487 Human mast cell-expressed membrane proteins
12/29/2005US20050288249 Testing a compound for the ability to inhibit PKG I alpha; testing the compound for the ability to inhibit PKG I beta; identifying the compound as a candidate drug useful in the treatment of pain ifit selectively inhibits PKG I alpha relative to PKG I beta .
12/29/2005US20050288243 Methods and compositions for treating gain-of-function disorders using RNA interference
12/29/2005US20050288227 Use of thioredoxin measurements for diagnostics and treatments
12/29/2005US20050288225 Modulators of intracellular inflammation, cell death and cell survival pathways
12/29/2005US20050288224 Novel protein, a gene coding therefor and a method of using the same
12/29/2005US20050287680 Multianalyte assay method
12/29/2005US20050287662 Helper-free stocks of recombinant adeno-associated virus vectors
12/29/2005US20050287648 Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof
12/29/2005US20050287647 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
12/29/2005US20050287644 Methods for producing and culturing rabbit-mouse hybridomas and monoclonal antibodies secreted by rabbit-mouse hybridomas
12/29/2005US20050287638 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents
12/29/2005US20050287635 RTD receptor
12/29/2005US20050287624 Modified sarcosine oxidases, modified sarcosine oxidase genes, and methods for preparing the modified sarcosine oxidases
12/29/2005US20050287623 Method for detecting reactive metabolites using stable-isotope trapping and mass spectroscopy
12/29/2005US20050287622 A peptide substrate for use as site of botulinum or tetnaus neurotoxin protease action and in identifying modulator which inhibit neurotoxic activity; prevention and treatment of food poisoning; fluorescence resonant energy transfer assay
12/29/2005US20050287621 Chip and apparatus for acetylcholinesterase inhibitor detection and method for using thereof
12/29/2005US20050287620 Method of determining analyte level using subcutaneous electrode
12/29/2005US20050287619 Method and reagent for measuring cholesterol in high-density lipoproteins
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005US20050287615 Screening assay to identify inhibitors of the murd enzyme using an activator-independent murd enzyme
12/29/2005US20050287610 Method for detecting the presence or risk of prostate cancer by detecting products of psa or klk2
12/29/2005US20050287609 Methods and compositions for detection of equine tapeworm infections
12/29/2005US20050287604 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
12/29/2005US20050287602 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell
12/29/2005US20050287601 Diagnostics and therapeutics for macular degeneration-related disorders
12/29/2005US20050287598 specific, high flow-through, and cost-effective assay for testing sample materials for the presence of a pathogenic protein including transthyretin and prion protein; sample is treated with a compound, e.g. a metalloendopeptidase, which selectively hydrolyzes prion protein but not abnormal form
12/29/2005US20050287597 Contacting cell that produces SIRT1 Tat deacetylase polypeptide and an acetylated Tat polypeptide with a test agent; determining level of acetylated Tat polypeptide in cell compared to level of acetylated Tat polypeptide in a control cell; drug screening; human immunodeficiency virus infections
12/29/2005US20050287596 Novel ligands and libraries of ligands
12/29/2005US20050287594 Activity-based probes having specificity to the active form of enzymes and receptors; screening for desired biological activities or target proteins
12/29/2005US20050287593 Use of cytokine expression to predict skin inflammation; methods of treatment
12/29/2005US20050287592 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks
12/29/2005US20050287590 Multi-functional microarrays and methods
12/29/2005US20050287589 High resolution DNA detection methods and devices
12/29/2005US20050287588 Breast cancer specific gene 1
12/29/2005US20050287587 host cells containing expression systems for production of nucleotide diphosphate 6-deoxy-mycarose; polyketides
12/29/2005US20050287585 In situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of shorter oligonucleotide fragments
12/29/2005US20050287584 Secreted proteins encoded by human chromosome 13
12/29/2005US20050287583 Methods and kits for isolating biological target materials using silica magnetic particles
12/29/2005US20050287582 Antibodies that specifically bind to FDF03
12/29/2005US20050287579 Genes for male accessory gland proteins in Drosophila melanogaster
12/29/2005US20050287578 Methods for RNA fluorescence in situ hybridization
12/29/2005US20050287577 flow channel for delivering the sample, magnetic particles immobilized in the flow channel,capable of capturing the target substance, aggregating fine particles in a desired region in the flow channel, introducing a sample into the flow channel, allowing fine particles to react with the target
12/29/2005US20050287576 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
12/29/2005US20050287575 System and method for improved genotype calls using microarrays
12/29/2005US20050287574 Genetic diagnostic method for SCD risk stratification
12/29/2005US20050287573 Lined multi-well plates
12/29/2005US20050287572 includes a microfluidic distribution channel; configured to distribute microreactor elements having copies of a sequencing template into a plurality of microfabricated thermal cycling chambers
12/29/2005US20050287571 determining the amount of defensin bound to sperm and comparing with a standard control, wherein a decrease in the amount from the standard control indicates a decrease in fertility in the male
12/29/2005US20050287570 Probe arrays for expression profiling of rat genes
12/29/2005US20050287569 For therapy and diagnosis of Escherichia coli infections
12/29/2005US20050287568 Novel human transferase proteins and polynucleotides encoding the same
12/29/2005US20050287567 JM-27 as a marker of benign prostatic hyperplasia
12/29/2005US20050287566 BICYCLIC LOCKED NUCLEOSIDE ANALOGUES; using an oligomer to isolate, purify, amplify, detect, identify, quantify or capture a natural or synthetic nucleic acid
12/29/2005US20050287565 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/29/2005US20050287563 Nucleic acid labeling compounds
12/29/2005US20050287562 Novel human kinase proteins and polynucleotides encoding the same
12/29/2005US20050287561 Genomic proxy microarrays to identify microbial quantitative trait loci
12/29/2005US20050287560 Method for preparing substrates having immobilized molecules and substrates
12/29/2005US20050287559 Genetic polymorphisms associated with vascular, methods of detection and uses thereof
12/29/2005US20050287558 SNPs of apolipoprotein B and modulation of their expression
12/29/2005US20050287557 Methods for identifying compounds for treating diabetes mellitus
1 ... 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 ... 3003